MENU
+Compare
NDTP
Stock ticker: OTC
AS OF
Nov 18 closing price
Price
$1.46
Change
-$0.04 (-2.67%)
Capitalization
233.61M

NDTP NDT Pharmaceuticals Inc. Forecast, Technical & Fundamental Analysis

NDT Pharmaceuticals Inc is a biotechnology company focused on developing revolutionary therapies for severe neurological disorders associated with traumatic brain injury... Show more

NDTP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for NDTP with price predictions
Nov 18, 2025

NDTP's Stochastic Oscillator stays in overbought zone for 3 days

The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for NDTP moved out of overbought territory on November 14, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NDTP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NDTP broke above its upper Bollinger Band on November 13, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 12, 2025. You may want to consider a long position or call options on NDTP as a result. In of 66 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NDTP just turned positive on November 13, 2025. Looking at past instances where NDTP's MACD turned positive, the stock continued to rise in of 34 cases over the following month. The odds of a continued upward trend are .

Following a +5 3-day Advance, the price is estimated to grow further. Considering data from situations where NDTP advanced for three days, in of 23 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 53 cases where NDTP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (23.122). P/E Ratio (0.000) is within average values for comparable stocks, (61.014). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.073). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (332.704).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NDTP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NDTP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
NDTP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
7325 Oswego Road
Phone
+1 315 451-7515
Employees
3
Web
https://www.NDTPharmaceuticals.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GHAIX48.980.13
+0.27%
VanEck Global Resources Fund I
VDMAX10.59N/A
N/A
Virtus KAR Developing Markets A
FWOCX18.14N/A
N/A
Fidelity Advisor Women's Leadership C
THORX46.45-0.45
-0.96%
Thornburg Global Opportunities R3
JSEAX22.05-0.27
-1.21%
JPMorgan International Equity A

NDTP and Stocks

Correlation & Price change

A.I.dvisor tells us that NDTP and MAIA have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NDTP and MAIA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NDTP
1D Price
Change %
NDTP100%
-2.67%
MAIA - NDTP
21%
Poorly correlated
+1.00%
MMIRF - NDTP
11%
Poorly correlated
N/A
MBXBF - NDTP
7%
Poorly correlated
-0.63%
NGENF - NDTP
6%
Poorly correlated
-0.85%
MEOBF - NDTP
4%
Poorly correlated
N/A
More